1. Home
  2. CVM vs PYN Comparison

CVM vs PYN Comparison

Compare CVM & PYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVM
  • PYN
  • Stock Information
  • Founded
  • CVM 1983
  • PYN 2002
  • Country
  • CVM United States
  • PYN United States
  • Employees
  • CVM N/A
  • PYN N/A
  • Industry
  • CVM Biotechnology: Biological Products (No Diagnostic Substances)
  • PYN Investment Managers
  • Sector
  • CVM Health Care
  • PYN Finance
  • Exchange
  • CVM Nasdaq
  • PYN Nasdaq
  • Market Cap
  • CVM 40.1M
  • PYN 34.5M
  • IPO Year
  • CVM 1987
  • PYN N/A
  • Fundamental
  • Price
  • CVM $0.40
  • PYN $5.74
  • Analyst Decision
  • CVM
  • PYN
  • Analyst Count
  • CVM 0
  • PYN 0
  • Target Price
  • CVM N/A
  • PYN N/A
  • AVG Volume (30 Days)
  • CVM 2.0M
  • PYN 19.9K
  • Earning Date
  • CVM 01-13-2025
  • PYN 01-01-0001
  • Dividend Yield
  • CVM N/A
  • PYN 5.07%
  • EPS Growth
  • CVM N/A
  • PYN N/A
  • EPS
  • CVM N/A
  • PYN N/A
  • Revenue
  • CVM N/A
  • PYN N/A
  • Revenue This Year
  • CVM N/A
  • PYN N/A
  • Revenue Next Year
  • CVM $152.91
  • PYN N/A
  • P/E Ratio
  • CVM N/A
  • PYN N/A
  • Revenue Growth
  • CVM N/A
  • PYN N/A
  • 52 Week Low
  • CVM $0.36
  • PYN $4.84
  • 52 Week High
  • CVM $3.08
  • PYN $6.60
  • Technical
  • Relative Strength Index (RSI)
  • CVM 38.00
  • PYN 46.37
  • Support Level
  • CVM $0.37
  • PYN $5.54
  • Resistance Level
  • CVM $0.42
  • PYN $5.79
  • Average True Range (ATR)
  • CVM 0.04
  • PYN 0.05
  • MACD
  • CVM -0.00
  • PYN 0.01
  • Stochastic Oscillator
  • CVM 11.83
  • PYN 80.00

About CVM Cel-Sci Corporation

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company's core capabilities that include are drug discovery, research, development and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

About PYN PIMCO New York Municipal Income Fund III of Beneficial Interest

PIMCO New York Municipal Income Fund III is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State, and New York City income tax. To pursue the objectives, the fund invests a majority of its net assets in municipal bonds that pay interest that is exempt from federal, New York State, and New York City income tax.

Share on Social Networks: